Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
ASCRS 2025: Recognizing and managing neurotrophic keratitis with cryopreserved amniotic membrane
Published on April 30, 2025
An emerging treatment approach for a commonly underdiagnosed ocular surface disease.
Continue reading on website
Other news
Does alcohol affect macular degeneration?
April 30, 2025
The leading source of breaking news, news analysis, and emerging research reports in optometry, Optometry Times® disseminates practical content by optometrists for optometrists that can be immediately applied to improve the clinical experience.
EssilorLuxottica’s Annual Shareholders’ Meeting Adopts All Resolutions Proposed
May 1, 2025
PARIS—EssilorLuxottica held its Annual Shareholders’ Meeting on April 30, 2025, the company announced, where shareholders approved all 17 resolutions submitted by the board of directors to the Ordinary and Extraordinary General Meeting. This included the distribution of a €3.95 dividend per share for the financial year 2024 and the compensation policy applicable to the company’s executive corporat